TW251237B - - Google Patents

Info

Publication number
TW251237B
TW251237B TW82107272A TW82107272A TW251237B TW 251237 B TW251237 B TW 251237B TW 82107272 A TW82107272 A TW 82107272A TW 82107272 A TW82107272 A TW 82107272A TW 251237 B TW251237 B TW 251237B
Authority
TW
Taiwan
Application number
TW82107272A
Other languages
Chinese (zh)
Original Assignee
Neose Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neose Pharm Inc filed Critical Neose Pharm Inc
Application granted granted Critical
Publication of TW251237B publication Critical patent/TW251237B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW82107272A 1992-07-31 1993-09-06 TW251237B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92251992A 1992-07-31 1992-07-31

Publications (1)

Publication Number Publication Date
TW251237B true TW251237B (de) 1995-07-11

Family

ID=25447150

Family Applications (1)

Application Number Title Priority Date Filing Date
TW82107272A TW251237B (de) 1992-07-31 1993-09-06

Country Status (3)

Country Link
AU (1) AU4993893A (de)
TW (1) TW251237B (de)
WO (1) WO1994003184A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU9502497D0 (en) * 1993-02-26 1995-10-30 Normark Use of oligosaccharide glycosides as inhibitors of bacterial adherence
AU709149B2 (en) * 1994-03-02 1999-08-19 Neose Technologies, Inc. Method for treating and inhibiting gastric and duodenal ulcers
SE9401826D0 (sv) * 1994-05-27 1994-05-27 Pharmacia Ab Anti-Helicobacter pyroli substance
US5665561A (en) * 1994-06-06 1997-09-09 The Rockefeller University Modulators of pneumococcal adherence to pulmonary and vascular cells and diagnostic and therapeutic applications
FR2721612B1 (fr) * 1994-06-23 1996-08-09 Idm Nouveaux dérivés d'oligosides, leur procédé de préparation et leurs applications.
US20020123508A1 (en) * 1995-12-22 2002-09-05 Osamu Kamoda Cyclohexane carbocyclic ester derivative and cyclodextrin complex and composition for treatment of helicobacter pylori infections
CA2253913A1 (en) * 1996-05-03 1997-11-13 Herbert Swarz Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
US6096725A (en) * 1997-07-02 2000-08-01 Neose Technologies, Inc. Methods of using αGal oligosaccharides as immune system targeting agents
AU2001287628A1 (en) 2000-07-17 2002-01-30 Hansa Medical Ab Antimicrobial agent
US20090054355A1 (en) 2007-01-12 2009-02-26 Shinshu University Proliferation Inhibitor Of Helicobacter Pylori Including Alpha-N-Acetyl-Glucosaminyl Bond-Containing Monosaccharide Derivatives
WO2010041746A1 (ja) 2008-10-10 2010-04-15 財団法人野口研究所 ピロリ菌増殖抑制剤
RU2410100C2 (ru) * 2009-03-30 2011-01-27 Александр Владимирович Диковский Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки
IT1394503B1 (it) * 2009-04-06 2012-07-05 Inalco Spa Sali di 6'-sialillattosio e processo per la loro sintesi e per la sintesi di altri alfa-sialiloligosaccaridi.
EP2593467A4 (de) * 2010-07-14 2014-03-12 Vancouver Biotech Ltd Kohlenhydrat-hapten-basierte anti-krebs-impfstoffe und antikörper-arzneimittel
RU2501549C1 (ru) 2012-08-30 2013-12-20 Авва Девелопмент Лтд Фармацевтическая композиция для лечения гастроэзофагеальной рефлюксной болезни

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE71293T1 (de) * 1986-09-18 1992-01-15 London Pharmacy Innovation Arzneiformulierung.
US4935406A (en) * 1988-09-20 1990-06-19 Marion Laboratories, Inc. Use of bismuth (phosph/sulf)ated saccharides against Camplyobacter-associated gastrointestinal disorders

Also Published As

Publication number Publication date
WO1994003184A1 (en) 1994-02-17
AU4993893A (en) 1994-03-03

Similar Documents

Publication Publication Date Title
DK0613608T3 (de)
DK0630289T3 (de)
BR9304651A (de)
BR9207065A (de)
DK0554977T3 (de)
DK0632741T3 (de)
DK0588007T3 (de)
DK0576346T3 (de)
DK0581129T3 (de)
DK0574276T3 (de)
DK0648175T3 (de)
DK0599441T3 (de)
BR9202713C1 (de)
DK0559942T3 (de)
DE9209779U1 (de)
AU632452B2 (de)
AU2098792A (de)
IN186386B (de)
IN185536B (de)
BR9304980A (de)
AU1866292A (de)
AU639200B1 (de)
AU1849392A (de)
AU1861992A (de)
AU1812892A (de)